SCHEMBL2804452

SCHEMBL2804452

C[C@@H]1CN(c2ncc3c(n2)-c2ccccc2C2(CCNCC2)C3)C[C@H](C)O1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 4/20 0.34
KDM1A O60341 2/20 0.34
PIK3CA P42336 1/20 0.34
KDM4E B2RXH2 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
PDE10A Q9Y233 1/20 0.33
ALDH1A1 P00352 6/20 0.33
HPGD P15428 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
LMNA P02545 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
KCNH2 Q12809 1/20 0.32
AOC3 Q16853 1/20 0.32
PTPN11 Q06124 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803020 0.80 HTR3A (0.38) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL2803911 0.80 HTR3A (0.35) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL2807816 0.79 ALDH1A1 (0.32) MTORMEN1KMT2APDE10AALDH1A1
SCHEMBL2805621 0.78 ALDH1A1 (0.40) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL2805709 0.78 CYP11B2 (0.37) MEN1KMT2APDE10AALDH1A1HPGD
SCHEMBL2805991 0.78 TSHR (0.42) MEN1KMT2AALDH1A1HPGDNPSR1
SCHEMBL2805444 0.77 ADRB2 (0.41) KCNH2
SCHEMBL2805783 0.77 ALDH1A1 (0.36) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL2806007 0.76 TLR9 (0.40)
SCHEMBL2804073 0.76 LMNA (0.43) KDM1AALDH1A1HPGDLMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 MTOR 1264/4885KDM1A 1589/4885PIK3CA 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.